MedTrace Logo

Efficacy of a Novel App-based Migraine Treatment Platform - a Pilot Study

NCT04106505 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2020-07-08

No results posted yet for this study

Summary

This study evaluates biofeedback delivered through a smartphone as a treatment for migraine in adolescents. Three out of four participants will receive treatment as smartphone delivered biofeedback training, and one out of four participants will receive treatment as a sham-biofeedback app.

Conditions

  • Migraine Disorders

Interventions

BEHAVIORAL

Biofeedback training via app on smartphone

Biofeedback training as described in biofeedback arm.

BEHAVIORAL

Sham-biofeedback training via app on smartphone

Sham-biofeedback training as described in sham-biofeedback arm.

Sponsors & Collaborators

  • Ullevaal University Hospital

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Øystein Risa · Norwegian University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-11
Primary Completion
2020-04-29
Completion
2020-04-29

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04106505 on ClinicalTrials.gov